Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid Onset of Action in SSTI
NCT00147511Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of linezolid in skin and soft tissue infections (SSTIs) (2 arms), sponsored by Pfizer. Primary endpoint: Time to defervescence. Started Jun 2003; status: completed.
02
Drugs
linezolid
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on NCT00147511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147511.